ClinicalTrials.gg
RecruitingNCT07781566Updated Aug 24, 2026

Perceptions of High and Low Intensity Speech Intervention in Children With a Cleft Palate

An observational study in Cleft Lip and Palate, Cleft Palate Children and Speech Therapy, sponsored by University Ghent. Recruiting at 1 site in Belgium. Open to participants aged 4 Years and older. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by University Ghent · Observational

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
45
Ages
4 Years and older
Sex
All
01

Study summary

A cleft (lip and) palate is the most common congenital abnormality of the face and skull with a significant social impact, affecting speech, hearing, feeding, oral behavior, dentition and satisfaction with appearance. These consequences have a long-term and negative impact on social integration and well-being. The World Health Organization (WHO) highlights the significant financial costs, including morbidity, health care costs, emotional distress and social exclusion for patients, their families and society. The purpose of this study is to compare high- and low-intensity speech intervention in children with a cleft (lip and) palate based on the perceptions of the providers of the intervention (primary care speech-language pathologists) and the recipients of the intervention (children with a cleft (lip and) palate and their parents). Individual semi-structured interviews will be conducted with both intervention providers and recipients to explore perceptions and experiences, as well as acceptability of the two speech intervention intensities. Potential participants will be told that the interview will be recorded. The actual interviews will take place at a location and time that is most convenient for the participants. Each interview will be recorded using a Roland R-05 high-quality audio recorder. After conducting the interviews, all participants will be asked to complete a questionnaire regarding their demographics. In addition, data regarding the type of cleft, time and manner of closure of the cleft, any secondary surgery and otological/audiological data will be collected from the medical records of the children with a cleft (lip and) palate. Based on this qualitative study, possible adjustments to the high-intensity therapy protocol can be made. In doing so, these modifications will be relevant to these key stakeholders. This will also facilitate the implementation and widespread use of high-intensity speech therapy in clinical speech therapy practice.

Read the detailed description

Objective:

This study will investigate the effect of high-intensity therapy through a large-scale study. The aim is to compare high- and low-intensity speech and language therapy for children with a cleft (lip and) palate, based on the perceptions and experiences of the intervention providers (speech and language therapists in primary healthcare) and recipients (children with a cleft (lip and) palate and their parents).

Hypothesis:

Qualitative studies do not start from the researcher's perspective, but from that of the participant. Consequently, no direct hypotheses are formulated. Nevertheless, a hypothesis is put forward based on previous qualitative studies by the research team. We hypothesise that a high-intensity speech intervention will result in more positive experiences and will be considered more acceptable by both the healthcare providers and the recipients of the intervention. This assumption is based on the expectation that an intensive intervention can reduce fatigue, dropout and the emotional burden of therapy, increase intrinsic motivation to participate in therapy, and improve articulation and speech intelligibility in the short term.

02

Conditions studied

  • Cleft Lip and Palate
  • Cleft Palate Children
  • Speech Therapy
  • Speech Disorders in Children
  • Intervention Intensity

Keywords

  • Qualitative research
  • Speech therapy
  • Intervention Intensity
  • Cleft lip and palate
03

In context

Cleft Lip

168 studies on the registry are indexed under Cleft Lip; 51 are open to participants now.

This study's planned enrollment of 45 is below the median of 100 across 49 observational studies indexed under Cleft Lip.

Browse Cleft Lip studies →

Lead sponsor

University Ghent is the lead sponsor of 350 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of children with cleft palate who participated in the associated randomized clinical trial evaluating high- and low-intensity speech therapy, their parents/caregivers, and the speech-language pathologists who provided the intervention. Participants will be selected from children and families enrolled in the clinical trial and from the speech-language pathologists providing the trial interventions.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Belgian Dutch-speaking children with a cleft palate with or without a cleft lip
  • Aged between 4 and 12 years,
  • Presence of at least one compensatory speech error in their speech based on the perceptual assessment of one experienced speech-language pathologist

Exclusion criteria

Exclusion Criteria:

  • Children with syndromic clefts
  • Oronasal fistula
  • Velopharyngeal insufficiency
  • Hearing disabilities based on pure tone audiometry (>25 dB HL)
  • Cognitive and/or related learning disabilities or neuromuscular disorders
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
45 participants (estimated)
Patient registry
No

Groups and cohorts

  • High-intensity speech therapy (HISI)

    Participants who received high-intensity speech therapy, consisting of five 30-minute sessions per week during two separate 2-week intervention periods, with a 6-week rest period between intervention periods.

    Behavioral: High-intensity speech therapy for children with cleft palate

  • Low-intensity speech therapy (LISI)

    Participants who received low-intensity speech therapy, consisting of two 30-minute sessions per week over a 10-week intervention period.

    Behavioral: Low-intensity speech therapy for children with cleft palate

Interventions

  • BehavioralHigh-intensity speech therapy for children with cleft palate

    High-intensity speech therapy consisted of five 30-minute speech therapy sessions per week over two separate 2-week periods, with a 6-week rest period between the two periods. The intervention comprised a total of 10 hours of speech therapy.

  • BehavioralLow-intensity speech therapy for children with cleft palate

    Low-intensity speech therapy consisted of two 30-minute speech therapy sessions per week over a 10-week period. The intervention comprised a total of 10 hours of speech therapy.

06

What researchers measure

Primary outcomes

  1. Perceived acceptability of high- and low-intensity speech intervention

    Perceptions and experiences of children with cleft palate, their parents/caregivers, and speech-language pathologists regarding the acceptability of high-intensity and low-intensity speech therapy. Acceptability will be explored through semi-structured interviews and examined across the seven constructs of the Theoretical Framework of Acceptability: affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness, and self-efficacy. Qualitative thematic analysis will be used to identify perceptions, experiences, and factors influencing acceptability of the two treatment intensities.

    Time frame: Day 1

Secondary outcomes

  1. Perceived feasibility and burden of high- and low-intensity speech therapy

    Perceptions of children with cleft palate, their parents/caregivers, and speech-language pathologists regarding the practical feasibility and burden associated with high- and low-intensity speech therapy. This includes experiences related to treatment frequency and duration, travel, scheduling, school and family commitments, fatigue, and other competing demands. Data will be collected through semi-structured interviews and analysed qualitatively.

    Time frame: Day 1

  2. Perceived therapeutic value of high- and low-intensity speech therapy

    Perceptions of children with cleft palate, their parents/caregivers, and speech-language pathologists regarding the therapeutic value and perceived effectiveness of high- and low-intensity speech therapy. This includes perceptions of speech progress, continuity, repetition, intensity, and the extent to which the intervention supports speech development. Data will be collected through semi-structured interviews and analysed qualitatively.

    Time frame: Day 1

  3. Emotional and motivational experiences of high- and low-intensity speech therapy

    Emotional and motivational experiences of children with cleft palate, their parents/caregivers, and speech-language pathologists during high- and low-intensity speech therapy. This includes experiences of enjoyment, motivation, fatigue, frustration, and other emotional responses to the intervention. Data will be collected through semi-structured interviews and analysed qualitatively.

    Time frame: Day 1

  4. Treatment preferences and contextual factors influencing acceptability of speech therapy intensity

    Preferences of children with cleft palate, their parents/caregivers, and speech-language pathologists regarding high- and low-intensity speech therapy, and contextual factors influencing these preferences. Factors related to the child, family, therapist, treatment setting, scheduling, and everyday circumstances will be explored. Data will be collected through semi-structured interviews and analysed qualitatively to identify factors that facilitate or hinder acceptance of different treatment intensities.

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Alighieri C, Bettens K, Verbeke J, Van Lierde K. 'Sometimes I feel sad': A qualitative study on children's perceptions with cleft palate speech and language therapy. Int J Lang Commun Disord. 2023 Sep-Oct;58(5):1526-1538. doi: 10.1111/1460-6984.12879. Epub 2023 Apr 18. PubMed 37072901 ↗
  • Alighieri C, Bettens K, Verhaeghe S, Van Lierde K. Speech diagnosis and intervention in children with a repaired cleft palate: A qualitative study of Flemish private community speech-language pathologists' practices. Int J Speech Lang Pathol. 2022 Feb;24(1):53-66. doi: 10.1080/17549507.2021.1946153. Epub 2021 Jul 6. PubMed 34229538 ↗
  • Alighieri C, Peersman W, Bettens K, Van Herreweghe V, Van Lierde K. Parental perceptions and expectations concerning speech therapy-related cleft care - a qualitative study. J Commun Disord. 2020 Sep-Oct;87:106028. doi: 10.1016/j.jcomdis.2020.106028. Epub 2020 Jul 3. PubMed 32659479 ↗
  • Alighieri C, Van Lierde K, Cammu H, Vanoost L, Bettens K. The retrospective acceptability of high intensity versus low intensity speech intervention in children with a cleft palate: A qualitative study from the parents' point of view using the Theoretical Framework of Acceptability. Int J Lang Commun Disord. 2023 Mar;58(2):326-341. doi: 10.1111/1460-6984.12788. Epub 2022 Oct 3. PubMed 36189983 ↗
  • Alighieri C, Bettens K, Vanoost L, Demuynck K, Verhaeghe S, Van Lierde K. Parents' perceptions on speech therapy delivery models in children with a cleft palate: A mixed methods study. Int J Pediatr Otorhinolaryngol. 2021 Dec;151:110958. doi: 10.1016/j.ijporl.2021.110958. Epub 2021 Oct 27. PubMed 34736010 ↗
  • Alighieri C, Bettens K, Verhaeghe S, Van Lierde K. From excitement to self-doubt and insecurity: Speech-language pathologists' perceptions and experiences when treating children with a cleft palate. Int J Lang Commun Disord. 2021 Jul;56(4):739-753. doi: 10.1111/1460-6984.12624. Epub 2021 May 28. PubMed 34048135 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for Sep 2027, 30 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2026
First posted
Aug 24, 2026
StartActual
Mar 1, 2025
Primary completionEst.
Sep 2027
CompletionEst.
Dec 2027
Last update
Aug 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07781566
Lead sponsor
University Ghent
Collaborators
Research Foundation Flanders
Responsible party
Sponsor
First posted
Aug 24, 2026
Start date
Mar 1, 2025
Primary completion
Sep 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Aug 24, 2026

Study contacts

Tara Mouton
Contact
tara.mouton@ugent.be
+32496446308
Kristiane Van Lierde, Professor
principal investigator · University Ghent

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion